slides · global inventory
Clinical Trial Design
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 129
Current window 121-129
Pages 5
Rows per page 30
Framework
121-129 of 129
12
The slide outlines a clinical trial protocol with specific patient counts (n=43, 12, 13, 8, 10) and timeline milestones (weeks 1, 24, 28, 40, 52).Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
Clinical trial design flow chart.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide outlines a standard clinical trial progression from dose escalation to expansion, with specific patient enrollment targets.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
The slide outlines a multi-arm clinical development strategy with standardized trial designs (Part A/B) across different indications.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines two study arms (MM120 ODT 100 µg and Placebo) with a primary endpoint at week 6, followed by a 40-week extension.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide uses a timeline-like structure to show the progression from Part A to Part B for two distinct studies.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Market SizeLoop · Pattern Hunter1 hit
25
The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
13
Includes a flow diagram of the trial phases and a table of baseline characteristics.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a process-oriented visual to outline the study parameters and the three key focus areas (Safety, Efficacy, Biomarkers).NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit